February 3, 2022
IGM Biosciences to Present at the Guggenheim 2022 Oncology Conference
MOUNTAIN VIEW, Calif. , Feb. 03, 2022 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer , Chief Executive Officer, will present virtually at the
Additional Formats
Displaying 11 - 13 of 13